The Predictive Value of Clinical and Molecular Characteristics or Immunotherapy in Non-Small Cell Lung Cancer: A Meta-Analysis of Randomized Controlled Trials

BACKGROUND: This meta-analysis aimed to investigate the efficacy of immune checkpoint inhibitor (ICI)-based therapy in non-small cell lung cancer (NSCLC) patients with different clinical and molecular characteristics such as age, sex, histological type, performance status (PS), smoking status, drive...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Yangyang, Wang, Qin, Xie, Jingyuan, Chen, Mo, Liu, Hongbing, Zhan, Ping, Lv, Tangfeng, Song, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8453160/
https://www.ncbi.nlm.nih.gov/pubmed/34557415
http://dx.doi.org/10.3389/fonc.2021.732214

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8453160/
https://www.ncbi.nlm.nih.gov/pubmed/34557415
http://dx.doi.org/10.3389/fonc.2021.732214

Ejemplares similares